Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CURE Pharmaceutical Holding Corp. (CURR)
OTHER OTC:CURR
RESEARCH TOOLSreports
Holding CURR?
Track your performance easily
CURR Stock Chart & Stats
Day’s Range$0.08 - $0.12
52-Week Range― - ―
Previous Close$0.13
Volume1.25K
Average Volume (3M)N/A
Market Cap
$10.76M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Aug 15, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding71,376,799
10 Day Avg. Volume5,255
30 Day Avg. Volume12,281
Standard Deviation0.30
R-Squared0.00289
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.20
Price to Sales (P/S)9.47
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CURE Pharmaceutical Holding News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CURR FAQ
What was CURE Pharmaceutical Holding Corp.’s price range in the past 12 months?
Currently, no data Available
What is CURE Pharmaceutical Holding Corp.’s market cap?
Currently, no data Available
When is CURE Pharmaceutical Holding Corp.’s upcoming earnings report date?
CURE Pharmaceutical Holding Corp.’s upcoming earnings report date is Aug 15, 2023 which is 375 days ago.
How were CURE Pharmaceutical Holding Corp.’s earnings last quarter?
Currently, no data Available
Is CURE Pharmaceutical Holding Corp. overvalued?
According to Wall Street analysts CURE Pharmaceutical Holding Corp.’s price is currently Overvalued.
Does CURE Pharmaceutical Holding Corp. pay dividends?
CURE Pharmaceutical Holding Corp. does not currently pay dividends.
What is CURE Pharmaceutical Holding Corp.’s EPS estimate?
CURE Pharmaceutical Holding Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CURE Pharmaceutical Holding Corp. have?
Currently, no data Available
What happened to CURE Pharmaceutical Holding Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CURE Pharmaceutical Holding Corp.?
Currently, no hedge funds are holding shares in CURR
---
CURE Pharmaceutical Holding Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical Holding Corp. focuses on the development and manufacturing of drug formulation and drug delivery technologies in novel dosage forms. Its commercial products include CURE 3068, and CURE 5079. The company was founded on May 15, 2014 and is headquartered in Oxnard, CA.
---
Technical Analysis
---